153 results
8-K
ARAV
Aravive Inc
19 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:10pm
, there can be no assurance that, if the Company does appeal the delisting determination by Nasdaq to the hearings panel, that such appeal would … to a hearings panel pursuant to the procedures set forth in the applicable Nasdaq Listing Rules. However, there can be no assurance that, if the Company
8-K
bpiydapifd6f5qsv31
2 Aug 23
Aravive Announces Top-Line Results from Phase 3 AXLerate-OC Study of Batiraxcept in Platinum-Resistant Ovarian Cancer
4:18pm
424B3
0sqltnlmgkhyic90e
29 Nov 22
Prospectus supplement
4:05pm
8-K/A
EX-10.1
6vmedu3rm34 yfiic3
28 Oct 22
Other Events
4:05pm
8-K
EX-10.1
1w3k jdzbgoc61ul
26 Oct 22
Aravive Announces Approximately $41.5 Million Private Placement Financing
4:35pm